Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03
Titel:
Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03
Auteur:
D'Addario, G. Rauch, D. Stupp, R. Pless, M. Stahel, R. Mach, N. Jost, L. Widmer, L. Tapia, C. Bihl, M. Mayer, M. Ribi, K. Lerch, S. Bubendorf, L. Betticher, D.C.